CuraGen Corporation's majority-owned subsidiary 454 Life Sciences has announced that research on small RNAs, conducted by Cold Spring Harbor Laboratory, has revealed the dual role of the ARGONAUTE 4 ...
Stuart Milstein appointed Chief Platform Officer, bringing decades of experience in oligonucleotide drug development to underpin Aerska’s platform R&DLisa Taylor Ash joins Board of Directors, ...
Dublin, March 13, 2026 (GLOBE NEWSWIRE)-- The "Amvuttra Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する